JOSEPH LEWIS

CIK 1015747 · last filed 2024-11-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$273.78M

Companies

7

Total Filings

20

Lifetime Open-Market Net

-$101.09M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INSG 10%+ Owner 1,800,186 $11.09 $19.96M $58.52M 10 2024-11-12
iTeos Therapeutics, Inc. (ITOS) Delisted 10%+ Owner 2,946,915 $10.15 $29.91M -$223.71M 3 2024-05-14
TNGX 10%+ Owner 8,203,642 $30.94 $253.82M $45.75M 2 2023-10-17
Odonate Therapeutics, Inc. (ODT) Delisted 10%+ Owner 4,757,086 $1.12 $5.33M -$6.19M 1 2021-11-19
Carisma Therapeutics Inc. (EBIO) Delisted 10%+ Owner 1,390,712 -$11.44M 1 2016-06-14
Mirati Therapeutics, Inc. (MRTX) Delisted 10%+ Owner 522,500 $58.70 $30.67M $38.12M 2 2015-09-18
SOPHIRIS BIO INC. (SPHS) Delisted 10%+ Owner 161,447 -$2.15M 1 2014-12-17

Recent Filings · Page 2 of 2

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-09-24 INSG Mixed +2,121,290 $0 EDGAR
2021-07-30 INSG Grant (A) +28,442 $0 EDGAR
2021-05-11 INSG Grant (A) +12,484 $0 EDGAR
2019-08-13 INSG Grant (A) +14,000 $14.00M EDGAR
2019-03-29 INSG Mixed +6,332,550 $15.96M EDGAR
2018-12-20 INSG Buy (P) +19,505,458 $58.52M EDGAR
2016-06-14 Carisma Therapeutics Inc. (EBIO) Delisted Sell (S) −4,168,000 -$11.44M EDGAR
2015-09-18 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed +225,000 $10.12M EDGAR
2014-12-17 SOPHIRIS BIO INC. (SPHS) Delisted Sell (S) −3,525,916 -$2.15M EDGAR
2013-10-28 Mirati Therapeutics, Inc. (MRTX) Delisted Buy (P) +1,600,000 $28.00M EDGAR
Showing 1120 of 20
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.